Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway

  • Authors:
    • Yan Jiang
    • Hanjie Xu
    • Jiafei Wang
  • View Affiliations

  • Published online on: April 28, 2016     https://doi.org/10.3892/ol.2016.4511
  • Pages: 4203-4207
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Alantolactone is the active ingredient in frankincense, and is extracted from the dry root of elecampane. It has a wide variety of uses, including as an insect repellent, antibacterial, antidiuretic, analgesic and anticancer agent. In addition, alantolactone induces apoptosis of human cervical cancer cells, however, its mechanism of action remains to be elucidated. Therefore, the present study investigated whether alantolactone was able to induce apoptosis of human cervical cancer cells, and its potential mechanisms of action were analyzed. Treatment of HeLa cells with alantolactone (0, 10, 20, 30, 40, 50 and 60 µM) for 12 h significantly inhibited growth in a dose‑dependent manner. Cells treated with 30 µM of alantolactone for 0, 3, 6 and 12 h demonstrated marked induction of apoptosis in a time‑dependent manner. Treatment of HeLa cells with 30 µM of alantolactone for 0, 3, 6 and 12 h significantly induced the generation of reactive oxygen species (ROS) and inhibited glutathione (GSH) production in HeLa cells in a dose‑dependent manner. Alantolactone additionally markedly inhibited the Bcl‑2/Bax signaling pathway in HeLa cells. Therefore, administration of alantolactone induced apoptosis of human cervical cancer cells via ROS generation, GSH depletion and inhibition of the Bcl-2/Bax signaling pathway.

References

1. 

Yau Hsiung W and Abdul Kadir H: Leea indica ethyl acetate fraction induces growth-inhibitory effect in various cancer cell lines and apoptosis in ca ski human cervical epidermoid carcinoma cells. Evid Based Complement Alternat Med. 2011:2930602011.PubMed/NCBI

2. 

Einck JP, Hudson A, Shulman AC, Yashar CM, Dieng MM, Diagne M, Gueye L, Gningue F, Gaye PM, Fisher BJ, et al: Implementation of a high-dose-rate brachytherapy program for carcinoma of the cervix in Senegal: A pragmatic model for the developing world. Int J Radiat Oncol Biol Phys. 89:462–467. 2014. View Article : Google Scholar : PubMed/NCBI

3. 

Misra JS, Srivastava AN and Das V: Single life time cytological screening in high risk women as an economical and feasible approach to control cervical cancer in developing countries like India. Asian Pac J Cancer Prev. 16:859–862. 2015. View Article : Google Scholar : PubMed/NCBI

4. 

Di Gao Z, Pan Q, Lv H, Sun Y, Ma X, Qin Z and Sun YP: HPV genotypes in paraffin sections of non-cervical squamous cell carcinoma in Qingdao of China. Oncol Lett. 5:1219–1222. 2013.PubMed/NCBI

5. 

Bigoni J, Gundar M, Tebeu PM, Bongoe A, Schäfer S, Fokom-Domgue J, Catarino R, Tincho EF, Bougel S, Vassilakos P and Petignat P: Cervical cancer screening in sub-Saharan Africa: A randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer. 137:127–134. 2015. View Article : Google Scholar : PubMed/NCBI

6. 

Gerli S, Bavetta F and Di Renzo GC: Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: Polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study. Eur Rev Med Pharmacol Sci. 16:1994–1998. 2012.PubMed/NCBI

7. 

Rodriguez EF, Reynolds JP, Jenkins SM, Winter SM, Henry MR and Nassar A: Atypical squamous cells of undetermined significance in patients with HPV positive DNA testing and correlation with disease progression by age group: An institutional experience. Int J Clin Exp Pathol. 5:428–435. 2012.PubMed/NCBI

8. 

Xiang T, Du L, Pham P, Zhu B and Jiang S: Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway. Cancer Lett. 364:79–88. 2015. View Article : Google Scholar : PubMed/NCBI

9. 

Singh M, Bhui K, Singh R and Shukla Y: Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sci. 93:7–16. 2013. View Article : Google Scholar : PubMed/NCBI

10. 

Dupuis G, Mitchell JC and Towers GH: Reaction of alantolactone, an allergenic sesquiterpene lactone, with some amino acids. Resultant loss of immunologic reactivity. Can J Biochem. 52:575–581. 1974. View Article : Google Scholar : PubMed/NCBI

11. 

Yao Y, Xia D, Bian Y, Sun Y, Zhu F, Pan B, Niu M, Zhao K, Wu Q, Qiao J, et al: Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance. Apoptosis. 20:1122–1133. 2015. View Article : Google Scholar : PubMed/NCBI

12. 

Zhang J, Li Y, Duan D, Yao J, Gao K and Fang J: Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells. Biochem Pharmacol. 2015.(In press).

13. 

Lim HS, Jin SE, Kim OS, Shin HK and Jeong SJ: Alantolactone from Saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF-α and IFN-γ-induced in HaCaT cells. Phytother Res. 29:1088–1096. 2015. View Article : Google Scholar : PubMed/NCBI

14. 

Ketai W, Huitao L, Yunkun Z, Xingguo C, Zhide H, Yucheng S and Xiao M: Separation and determination of alantolactone and isoalantolactone in traditional Chinese herbs by capillary electrophoresis. Talanta. 52:1001–1005. 2000. View Article : Google Scholar : PubMed/NCBI

15. 

Khan M, Yi F, Rasul A, Li T, Wang N, Gao H, Gao R and Ma T: Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life. 64:783–794. 2012. View Article : Google Scholar : PubMed/NCBI

16. 

Jarrett SG, Albon J and Boulton M: The contribution of DNA repair and antioxidants in determining cell type-specific resistance to oxidative stress. Free Radic Res. 40:1155–1165. 2006. View Article : Google Scholar : PubMed/NCBI

17. 

Liao S, Xiao S, Zhu G, Zheng D, He J, Pei Z, Li G and Zhou Y: CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer. Oncol Rep. 32:2703–2709. 2014.PubMed/NCBI

18. 

Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT and Kim JJ: An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 33:2830–2841. 2015. View Article : Google Scholar : PubMed/NCBI

19. 

Shi Y, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH and Li YX: Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway. J Biomol Screen. 16:525–535. 2011. View Article : Google Scholar : PubMed/NCBI

20. 

Khan M, Li T, Khan Ahmad MK, Rasul A, Nawaz F, Sun M, Zheng Y and Ma T: Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. BioMed Res Int. 2013:7198582013. View Article : Google Scholar : PubMed/NCBI

21. 

Yang J, Xiao YL, He XR, Qiu GF and Hu XM: Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells. J Asian Nat Prod Res. 12:185–193. 2010. View Article : Google Scholar : PubMed/NCBI

22. 

He L, Nan MH, Oh HC, Kim YH, Jang JH, Erikson RL, Ahn JS and Kim BY: Asperlin induces G2/M arrest through ROS generation and ATM pathway in human cervical carcinoma cells. Biochem Biophys Res Commun. 409:489–493. 2011. View Article : Google Scholar : PubMed/NCBI

23. 

Agostinelli E and Seiler N: Non-irradiation-derived reactive oxygen species (ROS) and cancer: Therapeutic implications. Amino Acids. 31:341–355. 2006. View Article : Google Scholar : PubMed/NCBI

24. 

Zhang Y, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH and Li YX: Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway. Mol Med Rep. 8:967–972. 2013.PubMed/NCBI

25. 

Kim YT, Kim SW, Yoon BS, Cho HJ, Nahm EJ, Kim SH, Kim JH and Kim JW: Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol. 105:199–204. 2007. View Article : Google Scholar : PubMed/NCBI

26. 

Srivastava K, Paul S, Chufal KS, Shamsundar SD, Lal P, Pant MC, Bhatt M, Singh S and Gupta R: Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial. Asia Pac J Clin Oncol. 9:349–356. 2013. View Article : Google Scholar : PubMed/NCBI

27. 

Fan S, Yu Y, Qi M, Sun Z, Li L, Yao G, Tashiro S, Onodera S and Ikejima T: P53-mediated GSH depletion enhanced the cytotoxicity of NO in silibinin-treated human cervical carcinoma HeLa cells. Free Radic Res. 46:1082–1092. 2012. View Article : Google Scholar : PubMed/NCBI

28. 

Kwaśniewska A, Tukendorf A and Semczuk M: Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia. Eur J Gynaecol Oncol. 18:196–199. 1997.PubMed/NCBI

29. 

Moon HJ and Park WH: Butylated hydroxyanisole inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis and GSH depletion. Mol Cell Biochem. 349:179–186. 2011. View Article : Google Scholar : PubMed/NCBI

30. 

Chan HW, Liu T, Verdile G, Bishop G, Haasl RJ, Smith MA, Perry G, Martins RN and Atwood CS: Copper induces apoptosis of neuroblastoma cells via post-translational regulation of the expression of Bcl-2-family proteins and the tx mouse is a better model of hepatic than brain Cu toxicity. Int J Clin Exp Med. 1:76–88. 2008.PubMed/NCBI

31. 

Li J, Wang H, Ma Z, Fan W, Li Y, Han B, Zhang Z and Wang J: TAT-Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl-2, caspase-3 and survivin expression. Exp Ther Med. 3:1033–1038. 2012.PubMed/NCBI

32. 

Ji M, Yuan L, Lv X, Dong W and Peng X: EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. Exp Ther Med. 8:919–924. 2014.PubMed/NCBI

33. 

Mi XG, Song ZB, Wu P, Zhang YW, Sun LG, Bao YL, Zhang Y, Zheng LH, Sun Y, Yu CL, et al: Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression. Toxicol Lett. 224:349–355. 2014. View Article : Google Scholar : PubMed/NCBI

34. 

Zhao P, Pan Z, Luo Y, Zhang L, Li X, Zhang G, Zhang Y, Cui R, Sun M and Zhang X: Alantolactone induces apoptosis and cell cycle arrest on lung squamous cancer SK-MES-1 cells. J Biochem Mol Toxicol. 29:199–206. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2016
Volume 11 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Jiang, Y., Xu, H., & Wang, J. (2016). Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway. Oncology Letters, 11, 4203-4207. https://doi.org/10.3892/ol.2016.4511
MLA
Jiang, Y., Xu, H., Wang, J."Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway". Oncology Letters 11.6 (2016): 4203-4207.
Chicago
Jiang, Y., Xu, H., Wang, J."Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway". Oncology Letters 11, no. 6 (2016): 4203-4207. https://doi.org/10.3892/ol.2016.4511